Pinnacle 21
Employees at Pinnacle 21 do tech work that means something. Their software enables key transitions in the clinical trial data pipeline and streamlines regulatory approvals for drugs and medical devices, getting new treatments to patients faster. Pinnacle 21 supplies its SaaS platform to the US FDA, Japan’s PMDA, 24 of the top 25 biopharma firms, and many more biotechs. It ensures clinical trial data comply with the standards of both government agencies and trial sponsors.
On its way from the clinic to a government agency, a data point goes through many steps, and Pinnacle 21 has processed over 30 trillion (with a T!) of them. With strong product-market fit and an aggressive roadmap fueled by their 2021 acquisition by Certara (NASDAQ: CERT), the team is quickly becoming the one-stop data brokerage for the life sciences.
Learn More